companydata.dkcompanydata.dk

Freya Biosciences License ApS: Financial statements 2024

CVR: 41372079

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Freya Biosciences License ApS (CVR 41372079) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -30,358 and a net result of DKK -30,358 compared with DKK -24,000 the year before. Equity in the 2024 report amounted to DKK 315,634. The solvency ratio was 72.2%.

Gross Profit
DKK -30,358
Profit/Loss
DKK -30,358
Equity
DKK 315,634
Total Assets
DKK 437,418

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--30K-30K316K-
2023--24K-24K195K-
2022--48K-48K105K-
20210-38K-38K19K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

David Lawrence Stern joins the board of Freya Biosciences License ApSSep 30, 2024

As of September 30, 2024, David Lawrence Stern has joined the board of directors of Freya Biosciences License ApS.

Danmarks Eksport- og Investeringsfond registered as owner of Freya Biosciences License ApSSep 30, 2024

As of September 30, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Freya Biosciences License ApS with an ownership share of 10%.

Registered as owner of Freya Biosciences License ApSSep 30, 2024

As of September 30, 2024, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.

Registered as owner of Freya Biosciences License ApSSep 30, 2024

As of September 30, 2024, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.

Freya Biosciences License ApS: The 2023 annual report is outJun 25, 2024

Freya Biosciences License ApS has published its annual report for 2023. Gross profit came to DKK -24,000, and the net result was DKK -24,000.

About Freya Biosciences License ApS

Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.

Source: annual report 2025, Danish Business Authority

Other financial years